InMode (INMD - Free Report) could be a solid choice for investors given the company's remarkably improving earnings outlook. While the stock has been a strong performer lately, this trend might continue since analysts are still raising their earnings estimates for the company.
Analysts' growing optimism on the earnings prospects of this maker of cosmetic surgery devices is driving estimates higher, which should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. This insight is at the core of our stock rating tool -- the Zacks Rank.
The five-grade Zacks Rank system, which ranges from a Zacks Rank #1 (Strong Buy) to a Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record of outperformance, with Zacks #1 Ranked stocks generating an average annual return of +25% since 2008.
Consensus earnings estimates for the next quarter and full year have moved considerably higher for InMode, as there has been strong agreement among the covering analysts in raising estimates.
The chart below shows the evolution of forward 12-month Zacks Consensus EPS estimate:
12 Month EPS
Current-Quarter Estimate Revisions
The company is expected to earn $0.30 per share for the current quarter, which represents a year-over-year change of -28.57%.
Over the last 30 days, one estimate has moved higher for InMode compared to no negative revisions. As a result, the Zacks Consensus Estimate has increased 575%.
Current-Year Estimate Revisions
For the full year, the earnings estimate of $1.29 per share represents a change of -20.86% from the year-ago number.
There has been an encouraging trend in estimate revisions for the current year as well. Over the past month, one estimate has moved up for InMode versus no negative revisions. This has pushed the consensus estimate 246.67% higher.
Favorable Zacks Rank
Thanks to promising estimate revisions, InMode currently carries a Zacks Rank #2 (Buy). The Zacks Rank is a tried-and-tested rating tool that helps investors effectively harness the power of earnings estimate revisions and make the right investment decision. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
Our research shows that stocks with Zacks Rank #1 (Strong Buy) and 2 (Buy) significantly outperform the S&P 500.
While strong estimate revisions for InMode have attracted decent investments and pushed the stock 10% higher over the past four weeks, further upside may still be left in the stock. So, you may consider adding it to your portfolio right away.